Both in Lab Analytical Instruments
10x Genomics vs Revvity
Over the past year TXG returned +411.8% and RVTY returned +68.9%; their daily moves had a correlation of 0.50.
TXG +411.8% RVTY +68.9%Growth of $1, one year, split-adjusted
| Metric | TXG | RVTY |
|---|---|---|
| Price | $70.11 | $157.00 |
| Market cap | $9.13B | $17.52B |
| Today | −14.03% | −5.30% |
| 1 month | −21.0% | +5.3% |
| 6 months | +212.6% | +81.1% |
| Year to date | +329.9% | +62.3% |
| 1 year | +443.5% | +64.7% |
| Revenue growth (YoY) | −12.6% | +1.3% |
| Gross margin | 74.5% | 57.1% |
| Net margin | −11.9% | 7.1% |
| P/E (TTM) | — | 73.7× |
| Price / sales | 14.8× | 6.0× |
| Net cash | $552.0M | -$2.18B |
| Dividend yield | — | 0.18% |
| Volatility (60d) | 87.8% | 36.7% |
| Short % of float | 10.9% | 5.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).